Butterfly Network, Inc.

BFLY trades at just $1.4B despite pioneering handheld ultrasound technology in a massive healthcare imaging market. The RSI of 61.7 suggests early momentum without extreme overbought conditions, while the 12.28% short float indicates meaningful skepticism persists. The absence of a P/E ratio signals the company remains unprofitable, which explains both the compressed valuation and bearish positioning. This setup presents classic risk-reward tension: either a pre-profitability growth story with runway, or a cash-burn concern that shorts are rightfully questioning. The stock's distance from its 52-week high leaves room for either direction.